Literature DB >> 22592909

Quercetin inhibits IL-1β-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast.

Myung-Soon Sung1, Eun-Gyeong Lee, Hyun-Soon Jeon, Han-Jung Chae, Seoung Ju Park, Yong Chul Lee, Wan-Hee Yoo.   

Abstract

This study was aimed to determine the effects of quercetin on the interleukin-1β (IL-1β)-induced proliferation of rheumatoid synovial fibroblasts (RASFs) and production of matrix metalloproteinases (MMPs), cyclooxygenase (COX), and prostaglandin E2 (PGE2) by RASFs. The proliferation and apoptosis of RASFs was evaluated with CCK-8 reagent and flow cytometry in the presence of IL-1with CCK-8 reagquercetin. The expression of MMPs, IL-1β enhanced the expression of MMP-1, MMP-3, tissue inhibitor of metalloproteinase (TIMP)-1, COXs, PGE2, and intracellular mitogen-activated protein kinase (MAPK) signalings including phosphorylated extracellular signal-regulated kinase (p-ERK), p-p38, phosphorylated c-Jun N-terminal kinase (p-JNK), and nuclear factor kB (NF-kB) were examined by immunoblotting or semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) in conditions as described above. Quercetin inhibits unstimulated and IL-1β-induced proliferation of RASFs and MMP-1, 3, COX-2 messenger ribonucleic acid and protein expression, PGE2 production induced with IL-1β. Quercetin also inhibits the phosphorylation of ERK-1/2, p38, JNK and activation of NF-kB by IL-1ed. These results indicate that quercetin inhibits synovial fibroblasts proliferation and MMPs, COX-2, and PGE2 production, which involved joint destruction in rheumatoid arthritis (RA), and suggest that it might be a new therapeutic agent for management of RA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592909     DOI: 10.1007/s10753-012-9473-2

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  30 in total

1.  Ethyl acetate fraction from Cudrania tricuspidata inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and MMPs, COX-2 and PGE2 production.

Authors:  Eun-Gyeong Lee; Sang-ll Lee; Han-Jung Chae; Seoung Ju Park; Yong Chul Lee; Wan-Hee Yoo
Journal:  Biol Res       Date:  2010-09-24       Impact factor: 5.612

2.  c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

Authors:  Z Han; D L Boyle; L Chang; B Bennett; M Karin; L Yang; A M Manning; G S Firestein
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.

Authors:  Hak-Yong Lee; Hyun-Soon Jeon; Eun-Kyung Song; Myung-Kwan Han; Sung-Il Park; Sang-Il Lee; Hee-Jin Yun; Jung-Ryul Kim; Jong-Suk Kim; Yong-Chul Lee; Sung-Il Kim; Hang-Rae Kim; Jin-Young Choi; Insoo Kang; Ho-Youn Kim; Wan-Hee Yoo
Journal:  Arthritis Rheum       Date:  2006-06

4.  The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis.

Authors:  J K Jackson; T Higo; W L Hunter; H M Burt
Journal:  Inflamm Res       Date:  2006-04       Impact factor: 4.575

5.  In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway.

Authors:  Mònica Comalada; Desirée Camuesco; Saleta Sierra; Isabel Ballester; Jordi Xaus; Julio Gálvez; Antonio Zarzuelo
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

6.  Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha.

Authors:  Yoshio Kumazawa; Kiichiro Kawaguchi; Hiroaki Takimoto
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

7.  Regulatory mechanisms of IL-2 and IFNgamma suppression by quercetin in T helper cells.

Authors:  Eun Sun Yu; Hyun Jung Min; Su Yeon An; Hee Yeon Won; Jeong Ho Hong; Eun Sook Hwang
Journal:  Biochem Pharmacol       Date:  2008-04-06       Impact factor: 5.858

8.  Anti-inflammatory action of Cudrania tricuspidata on spleen cell and T lymphocyte proliferation.

Authors:  Sung Ho Chang; Eun Jung Jung; Dong Gyun Lim; Baatartsogt Oyungerel; Kwan Il Lim; Erk Her; Wahn Soo Choi; Myung Ha Jun; Kang Duk Choi; Duck Jong Han; Song Cheol Kim
Journal:  J Pharm Pharmacol       Date:  2008-09       Impact factor: 3.765

9.  Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

Authors:  L J Crofford; R L Wilder; A P Ristimäki; H Sano; E F Remmers; H R Epps; T Hla
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653.

Authors:  Masataka Nishikawa; Akira Myoui; Tetsuya Tomita; Koichiro Takahi; Akihide Nampei; Hideki Yoshikawa
Journal:  Arthritis Rheum       Date:  2003-09
View more
  17 in total

1.  Protective effect of taraxasterol against rheumatoid arthritis by the modulation of inflammatory responses in mice.

Authors:  Shu-Hua Jiang; Li-Feng Ping; Feng-Yan Sun; Xiao-Lei Wang; Zhi-Juan Sun
Journal:  Exp Ther Med       Date:  2016-11-02       Impact factor: 2.447

Review 2.  Pharmacological Aspects of Natural Quercetin in Rheumatoid Arthritis.

Authors:  Mengshi Tang; Yan Zeng; Weijun Peng; Xi Xie; Yongyu Yang; Biting Ji; Fen Li
Journal:  Drug Des Devel Ther       Date:  2022-06-29       Impact factor: 4.319

3.  p53 contributes to quercetin-induced apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Peng Xiao; Yingjie Hao; Xu Zhu; Xuejian Wu
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

4.  Flavonoid quercetin-methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis.

Authors:  Nagaraja Haleagrahara; Kelly Hodgson; Socorro Miranda-Hernandez; Samuel Hughes; Anupama Bangra Kulur; Natkunam Ketheesan
Journal:  Inflammopharmacology       Date:  2018-04-03       Impact factor: 4.473

Review 5.  Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?

Authors:  Md Soriful Islam; Most Mauluda Akhtar; Andrea Ciavattini; Stefano Raffaele Giannubilo; Olga Protic; Milijana Janjusevic; Antonio Domenico Procopio; James H Segars; Mario Castellucci; Pasquapina Ciarmela
Journal:  Mol Nutr Food Res       Date:  2014-06-30       Impact factor: 5.914

6.  Intra-Articular Delivery of Quercetin Using Thermosensitive Hydrogel Attenuate Cartilage Degradation in an Osteoarthritis Rat Model.

Authors:  Sze-Wing Mok; Sai-Chuen Fu; Yau-Chuk Cheuk; I-Ming Chu; Kai-Ming Chan; Ling Qin; Shu-Hang Yung; Ki-Wai Kevin Ho
Journal:  Cartilage       Date:  2018-08-30       Impact factor: 4.634

7.  Conditioned Medium from Tonsil-Derived Mesenchymal Stem Cells Relieves CCl4-Induced Liver Fibrosis in Mice.

Authors:  Yu-Hee Kim; Kyung-Ah Cho; Minhwa Park; Han Su Kim; Joo-Won Park; So-Youn Woo; Kyung-Ha Ryu
Journal:  Tissue Eng Regen Med       Date:  2018-10-19       Impact factor: 4.169

Review 8.  The p53 status in rheumatoid arthritis with focus on fibroblast-like synoviocytes.

Authors:  Mahdi Taghadosi; Mehrnoosh Adib; Ahmadreza Jamshidi; Mahdi Mahmoudi; Elham Farhadi
Journal:  Immunol Res       Date:  2021-05-13       Impact factor: 2.829

9.  Mediators of inflammation-induced bone damage in arthritis and their control by herbal products.

Authors:  Siddaraju M Nanjundaiah; Brian Astry; Kamal D Moudgil
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-07       Impact factor: 2.629

10.  Pro-inflammatory mediation of myoblast proliferation.

Authors:  Jeffrey S Otis; Sarah Niccoli; Nicole Hawdon; Jessica L Sarvas; Melinda A Frye; Adam J Chicco; Simon J Lees
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.